Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.17.4.4 extracted from

  • Wang, D.; Chen, H.; Momary, K.M.; Cavallari, L.H.; Johnson, J.A.; Sadee, W.
    Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement (2008), Blood, 112, 1013-1021.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine the single nucleotide polymorphism G1639A is a suitable biomarker for warfarin dosing across ethnic populations. Preferential association of the promoter -1639 G allele with active chromatin Homo sapiens

Protein Variants

Protein Variants Comment Organism
additional information in vitro expression of VKORC1 gene constructs, including coding region and promoter, fails to reveal any genotype effect on transcription and mRNA processing Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q9BQB6
-
-

Source Tissue

Source Tissue Comment Organism Textmining
heart measurement of allelic mRNA expression Homo sapiens
-
liver measurement of allelic mRNA expression. Genotype effect of 2-fold allelic mRNA expression due to single nucleotide polymorphisms -1639G>A and 1173C Homo sapiens
-
lymphocyte B lymphocyte, measurement of allelic mRNA expression Homo sapiens
-